MILESTONE: strona spółki
21.01.2021, 23:13
MMD Receiving a Notice of Allowance for U.S Patent Related to CompuFlo Disposables
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced that Milestone Scientific, Inc. (NYSE:MLSS), the licensor and the majority shareholder of the Issuer has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent relating to the disposable component of Milestone’s CompuFlo® Instrument.
The Board of Directors of the Company commented that the Issuer’s clinical objectives have always been to focus on creating greater control and safety of its disposables. This aligns with the Company’s commercial strategy to ensure its disposables are protected due to the high margin, recurring revenue nature of these sales. This patent will cover the unique interactions of the disposable assembly and a micro-chip security verification feature embedded in the disposables, which provides numerous clinical and safety benefits for the patient and practitioner. This patent also covers the use of an embedded security chip, which is intended to enhance the safety and integrity of its system by preventing improper reuse of the disposables, as well as ensuring its instrument can only be used with authenticated disposables for the current and future systems. The Board of Directors of the Company believes that ensuring the use of only authorized disposable components is critical to CompuFlo’s performance, safety as well as the long-term financial success of the Company. The Board of Directors of the Company is proud to state that Milestone Scientific, the licensor and the majority shareholder of the Issuer currently holds more than 20 patents surrounding the injection and drug delivery systems, which further solidifies its leadership position in this market.
The Board of Directors of the Company commented that the Issuer’s clinical objectives have always been to focus on creating greater control and safety of its disposables. This aligns with the Company’s commercial strategy to ensure its disposables are protected due to the high margin, recurring revenue nature of these sales. This patent will cover the unique interactions of the disposable assembly and a micro-chip security verification feature embedded in the disposables, which provides numerous clinical and safety benefits for the patient and practitioner. This patent also covers the use of an embedded security chip, which is intended to enhance the safety and integrity of its system by preventing improper reuse of the disposables, as well as ensuring its instrument can only be used with authenticated disposables for the current and future systems. The Board of Directors of the Company believes that ensuring the use of only authorized disposable components is critical to CompuFlo’s performance, safety as well as the long-term financial success of the Company. The Board of Directors of the Company is proud to state that Milestone Scientific, the licensor and the majority shareholder of the Issuer currently holds more than 20 patents surrounding the injection and drug delivery systems, which further solidifies its leadership position in this market.